{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:14:21Z","timestamp":1792761261340,"version":"4.5.0"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,16]]},"abstract":"<jats:p>Heart failure (HF) is a chronic progressive clinical condition characterized by structural or functional impairment of the ventricles. The prevalence of HF is increasing, and it continues to be a significant cause of morbidity and mortality. Liver involvement during fibrosis in HF patients is associated with adverse clinical outcomes. Our study aimed to evaluate the relationship between noninvasive liver fibrosis indices and HF mortality. Our study was a retrospective analysis of patients with HF admitted to our hospital between 2017 and 2023. Patients were followed up until 2024 and divided into 2 groups according to mortality. The patients\u2019 liver fibrosis indices were calculated, and Cox regression analysis was performed to identify the independent predictors of mortality. Their ability to predict mortality was assessed using receiver operating characteristic Curve analysis, and the areas under the curve were compared. Our study included 2029 patients with HF. The mean follow-up period was 1655 days. The mortality rate was 9.5% (N\u2005=\u2005193). The aspartate aminotransferase (AST)\/alanine aminotransferase (ALT) ratio was not a predictor of HF mortality, whereas APRI and FIB-4 index were independent predictors of HF mortality. According to receiver operating characteristic curve analysis, the FIB-4 score was superior to the APRI in predicting mortality. The APRI had a specificity of 93.4% at a cutoff value of 1.0. The FIB-4 Score had a sensitivity of 89.6% at a cutoff value of 1.0. Our study found that AST\/ALT ratio did not predict HF mortality. However, our study found that the FIB-4 score was associated with mortality in all types of HF, and the APRI was associated with mortality in HFrEF and HFmrEF. These parameters can be calculated easily and practically from routine examinations and can be used in HF follow-up and prognosis estimation.<\/jats:p>","DOI":"10.1097\/md.0000000000047301","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:02:20Z","timestamp":1768849340000},"page":"e47301","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Association between noninvasive hepatic fibrosis indices and heart failure mortality"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6654-2521","authenticated-orcid":false,"given":"Selim","family":"Aydemir","sequence":"first","affiliation":[{"name":"Department of Cardiology, University of Health Sciences, Erzurum City Hospital, Erzurum, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8204-1505","authenticated-orcid":false,"given":"Sidar \u015eiyar","family":"Aydin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Atat\u00fcrk University Faculty of Medicine, Erzurum, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2178-6140","authenticated-orcid":false,"given":"Onur","family":"Altinkaya","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Health Sciences, Erzurum City Hospital, Erzurum, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6237-1398","authenticated-orcid":false,"given":"Murat","family":"\u00d6zmen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Health Sciences, Erzurum City Hospital, Erzurum, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4324-2846","authenticated-orcid":false,"given":"\u00d6mer Faruk","family":"Derman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5765-4281","authenticated-orcid":false,"given":"Emrah","family":"Aksakal","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Health Sciences, Erzurum City Hospital, Erzurum, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260119","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2024.06.002","article-title":"2024 ACC expert consensus decision pathway on clinical assessment, management, and trajectory of patients hospitalized with heart failure focused update: a report of the american college of cardiology solution set oversight committee.","volume":"84","author":"Hollenberg","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"R2-20260119","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017.","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"R3-20260119","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the american heart association.","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"R4-20260119","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no Other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease.","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"R5-20260119","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis.","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"R6-20260119","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"R7-20260119","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jchf.2018.10.007","article-title":"Heart failure and liver disease: cardiohepatic interactions.","volume":"7","author":"Xanthopoulos","year":"2019","journal-title":"JACC Heart Fail"},{"key":"R8-20260119","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/hep.30048","article-title":"Assessment of advanced liver fibrosis and the risk for hepatic decompensation in patients with congestive hepatopathy.","volume":"68","author":"Lemmer","year":"2018","journal-title":"Hepatology"},{"key":"R9-20260119","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.jacc.2013.03.042","article-title":"Cardiohepatic interactions in heart failure: an overview and clinical implications.","volume":"61","author":"Samsky","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R10-20260119","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/MOG.0000000000000621","article-title":"The utility of liver biopsy in 2020.","volume":"36","author":"Khalifa","year":"2020","journal-title":"Curr Opin Gastroenterol"},{"key":"R11-20260119","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2013.06.057","article-title":"Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.","volume":"145","author":"Angulo","year":"2013","journal-title":"Gastroenterology"},{"key":"R12-20260119","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update.","volume":"75","year":"2021","journal-title":"J Hepatol"},{"key":"R13-20260119","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease.","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"R14-20260119","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14744\/hf.2020.0006","article-title":"The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases.","volume":"1","author":"Kaya","year":"2020","journal-title":"Hepatol Forum"},{"key":"R15-20260119","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s12265-013-9522-8","article-title":"Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling.","volume":"7","author":"Motiwala","year":"2014","journal-title":"J Cardiovasc Transl Res"},{"key":"R16-20260119","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1002\/ehf2.13351","article-title":"Prognostic significance of liver stiffness assessed by fibrosis-4 index in patients with heart failure.","volume":"8","author":"Takae","year":"2021","journal-title":"ESC Heart Fail"},{"key":"R17-20260119","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/ehf2.13829","article-title":"Prognostic value of the liver fibrosis marker fibrosis-5 index in patients with acute heart failure.","volume":"9","author":"Maeda","year":"2022","journal-title":"ESC Heart Fail"},{"key":"R18-20260119","doi-asserted-by":"crossref","first-page":"e100618","DOI":"10.1371\/journal.pone.0100618","article-title":"Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure.","volume":"9","author":"Abe","year":"2014","journal-title":"PLoS One"},{"key":"R19-20260119","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/ejhf.2649","article-title":"Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF.","volume":"24","author":"Adamson","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"R20-20260119","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijcard.2018.04.129","article-title":"Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure.","volume":"265","author":"Valbusa","year":"2018","journal-title":"Int J Cardiol"},{"key":"R21-20260119","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ehf2.12222","article-title":"Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction.","volume":"5","author":"Yoshihisa","year":"2018","journal-title":"ESC Heart Fail"},{"key":"R22-20260119","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pcad.2020.02.010","article-title":"FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C.","volume":"63","author":"So-Armah","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"R23-20260119","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/ehf2.13317","article-title":"Fibrosis-4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction.","volume":"8","author":"Nakashima","year":"2021","journal-title":"ESC Heart Fail"},{"key":"R24-20260119","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12933-021-01374-8","article-title":"The association of hepatic steatosis and fibrosis with heart failure and mortality.","volume":"20","author":"Park","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"R25-20260119","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ejhf.3024","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (ESC) With the special contribution of the heart failure association (HFA) of the ESC.","volume":"26","author":"McDonagh","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"R26-20260119","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (ESC). developed with the special contribution of the heart failure association (HFA) of the ESC.","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"R27-20260119","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1572-0241.1998.044_c.x","article-title":"AST\/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.","volume":"93","author":"Sheth","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R28-20260119","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"R29-20260119","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"R30-20260119","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection.","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"R31-20260119","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R32-20260119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the american society of echocardiography and the european association of cardiovascular imaging.","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"R33-20260119","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/ejhf.630","article-title":"Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis.","volume":"18","author":"Gorter","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"R34-20260119","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1089-3261(02)00056-9","article-title":"The liver in heart failure.","volume":"6","author":"Giallourakis","year":"2002","journal-title":"Clin Liver Dis"},{"key":"R35-20260119","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cld.573","article-title":"Congestive hepatopathy.","volume":"8","author":"Hilscher","year":"2016","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"R36-20260119","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3390\/nu15030748","article-title":"Association between cardiovascular disease and liver disease, from a clinically pragmatic perspective as a cardiologist.","volume":"15","author":"Nakashima","year":"2023","journal-title":"Nutrients"},{"key":"R37-20260119","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R38-20260119","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review.","volume":"73","author":"Stahl","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R39-20260119","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/jcm10030467","article-title":"NAFLD and cardiovascular diseases: epidemiological, mechanistic and therapeutic considerations.","volume":"10","author":"Niederseer","year":"2021","journal-title":"J Clin Med"},{"key":"R40-20260119","doi-asserted-by":"crossref","first-page":"154770","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.","volume":"119","author":"Muzurovic","year":"2021","journal-title":"Metabolism"},{"key":"R41-20260119","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12933-020-01064-x","article-title":"Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study.","volume":"19","author":"Lee","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"R42-20260119","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1177\/0300060518782780","article-title":"Chronic heart failure in patients with nonalcoholic fatty liver disease: prevalence, clinical features, and relevance.","volume":"46","author":"Zhang","year":"2018","journal-title":"J Int Med Res"},{"key":"R43-20260119","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1136\/gutjnl-2021-325724","article-title":"Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.","volume":"71","author":"Simon","year":"2022","journal-title":"Gut"},{"key":"R44-20260119","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1097\/PAS.0000000000001163","article-title":"Heterogeneity of fibrosis in liver biopsies of patients with heart failure undergoing heart transplant evaluation.","volume":"42","author":"Dhall","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R45-20260119","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"R46-20260119","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2020.03.010","article-title":"Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease.","volume":"299","author":"Chen","year":"2020","journal-title":"Atherosclerosis"},{"key":"R47-20260119","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/hep4.1419","article-title":"Mortality related to nonalcoholic fatty liver disease is increasing in the United States.","volume":"3","author":"Paik","year":"2019","journal-title":"Hepatol Commun"},{"key":"R48-20260119","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.dld.2018.09.004","article-title":"Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"50","author":"Wijarnpreecha","year":"2018","journal-title":"Dig Liver Dis"},{"key":"R49-20260119","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study.","volume":"62","author":"VanWagner","year":"2015","journal-title":"Hepatology"},{"key":"R50-20260119","doi-asserted-by":"crossref","first-page":"e000598","DOI":"10.1136\/openhrt-2017-000598","article-title":"Liver stiffness assessed by fibrosis-4 index predicts mortality in patients with heart failure.","volume":"4","author":"Sato","year":"2017","journal-title":"Open Heart"},{"key":"R51-20260119","doi-asserted-by":"crossref","first-page":"e0173398","DOI":"10.1371\/journal.pone.0173398","article-title":"Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure.","volume":"12","author":"Valbusa","year":"2017","journal-title":"PLoS One"},{"key":"R52-20260119","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00380-017-1113-1","article-title":"The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failure.","volume":"33","author":"Takahashi","year":"2018","journal-title":"Heart Vessels"},{"key":"R53-20260119","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.amjcard.2018.10.027","article-title":"Relation of hepatic fibrosis in nonalcoholic fatty liver disease to left ventricular diastolic function and exercise tolerance.","volume":"123","author":"Canada","year":"2019","journal-title":"Am J Cardiol"},{"key":"R54-20260119","doi-asserted-by":"crossref","first-page":"e007241","DOI":"10.1161\/CIRCIMAGING.117.007241","article-title":"Association of liver fibrosis with cardiovascular diseases in the general population: the multi-ethnic study of atherosclerosis (MESA).","volume":"11","author":"Ostovaneh","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"R55-20260119","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ehf2.13222","article-title":"Non-alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues.","volume":"8","author":"Itier","year":"2021","journal-title":"ESC Heart Fail"},{"key":"R56-20260119","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/ehf2.13250","article-title":"Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT.","volume":"8","author":"Peters","year":"2021","journal-title":"ESC Heart Fail"},{"key":"R57-20260119","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.cgh.2024.03.045","article-title":"Liver fibrosis assessed via noninvasive tests is associated with incident heart failure in a general population cohort.","volume":"22","author":"Hydes","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R58-20260119","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3892\/ijmm_00000173","article-title":"Detection of the mitochondrial and catalytically active alanine aminotransferase in human tissues and plasma.","volume":"23","author":"Glinghammar","year":"2009","journal-title":"Int J Mol Med"},{"key":"R59-20260119","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/oby.2008.64","article-title":"NASH predicts plasma inflammatory biomarkers independently of visceral fat in men.","volume":"16","author":"Targher","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"R60-20260119","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jhep.2014.11.024","article-title":"The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.","volume":"62","author":"Lazo","year":"2015","journal-title":"J Hepatol"},{"key":"R61-20260119","doi-asserted-by":"crossref","first-page":"e4821","DOI":"10.1097\/MD.0000000000004821","article-title":"The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes.","volume":"95","author":"Zoppini","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"R62-20260119","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12876-019-1007-z","article-title":"Fibrosis-4 index at diagnosis is associated with all-cause mortality in patients with microscopic polyangiitis and granulomatosis with polyangiitis.","volume":"19","author":"Park","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"R63-20260119","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/14397595.2018.1558760","article-title":"Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: a retrospective monocentric study.","volume":"30","author":"Kim","year":"2020","journal-title":"Mod Rheumatol"},{"key":"R64-20260119","doi-asserted-by":"crossref","first-page":"e13856","DOI":"10.1111\/eci.13856","article-title":"The fibrosis-4 score is associated with long-term mortality in different phenotypes of acute heart failure.","volume":"52","author":"Tseng","year":"2022","journal-title":"Eur J Clin Invest"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:02:27Z","timestamp":1768849347000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047301","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"2024-10-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}